BridgeMD
Compares treatment options for Bronchopulmonary Dysplasia
Official title Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
ClinicalTrials.gov ID: NCT06821776
What this study is testing
- What it's testing
- Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 1
You may be able to join if
- Patients born \<32 weeks' gestation
- Currently admitted to the Le Bonheur NICU
- Grad 2 or 3 BPD (positive pressure or intubated at 36 weeks PMA)
- Signs of gastroesophageal reflux, chronic aspiration, or other feeding intolerance.
You likely can't join if
- Known gastrointestinal anomalies
- Unable to tolerate ≥100mL/kg/day enteral feeding
- Congenital anomalies likely to alter feeding techniques
- Surgical feeding tube in place or expected within the next 8 weeks
- Expected to remain hospitalized \<8 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Memphis, Tennessee, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 1 year. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.